J. Ambrosioni, A. Mamin, A. Hadengue, M. Bernimoulin, K. Samii, C

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
R. Cavallo  Clinical Microbiology and Infection 
Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines.
L. Boyanova  Clinical Microbiology and Infection 
H. Lepidi, F. Gouriet, D. Raoult  Clinical Microbiology and Infection 
Influence of hepatitis C and hepatitis G virus co-infection on viral and cellular dynamics in patients infected with human immunodeficiency virus following.
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones  J. Mensa, A. Trilla 
Migrant health—a cause for concern?
The relationship between tumour necrosis factor-α gene polymorphism and susceptibility and clearance of the persistent hepatitis B virus infection in.
Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients  O. Epaulard, C. Saint-Raymond,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Hepatitis B and C virus-related carcinogenesis
Infectious causes of cancer: an evolving educational saga
Virological tools to diagnose and monitor hepatitis C virus infection
G. Zhao, H. Zhai, Q. Yuan, S. Sun, T. Liu, L. Xie 
R. Cantón  Clinical Microbiology and Infection 
Hydatid disease Clinical Microbiology and Infection
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
E. Braun, K. Hussein, Y. Geffen, G. Rabino, Y. Bar-Lavie, M. Paul 
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Vector control: a cornerstone in the malaria elimination campaign
The role of vaccination in preventing pneumococcal disease in adults
Training for the infectious diseases speciality in Norway
Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels  B. Sarov, L. Novack, N.
Does it make sense to detect Streptococcus pyogenes during tonsillitis in Europe to prevent acute rheumatic fever?  S. Edouard, A. Michel-Lepage, D. Raoult 
Polymerase-chain reaction/electrospray ionization-mass spectrometry for the detection of bacteria and fungi in bronchoalveolar lavage fluids: a prospective.
CMI editorial report 2011 Clinical Microbiology and Infection
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Elements of design: the knowledge on which we build
W. van den Bijllaardt, I.T. Overdevest, A.G. Buiting, J.J. Verweij 
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
Hepatitis B and C virus-related carcinogenesis
Epidemiology of viral respiratory infections in a tertiary care centre in the era of molecular diagnosis, Geneva, Switzerland, 2011–2012  J. Ambrosioni,
Rapid spread of emerging Zika virus in the Pacific area
Survival of hepatitis A and E viruses in soil samples
Abstracts cont. Clinical Microbiology and Infection
Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial 
Factors related to the chronicity and evolution of hepatitis C infection in patients co- infected by the human immunodeficiency virus  R. Pérez-Cano, C.
A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures  A. Makristathis, S. Riss, A.M. Hirschl 
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
Current experience in treating invasive zygomycosis with posaconazole
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS  M. Rybicka,
An after-hours clinical liaison blood culture service—is it worth it?
Presence of sandflies infected with Leishmania infantum and Massilia virus in the Marseille urban area†   B. Faucher, R. Piarroux, C. Mary  Clinical Microbiology.
Statin use and clinical outcomes among pneumonia patients
W. Eugene Sanders, Christine C. Sanders 
Leishmaniasis in immunosuppressed individuals
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
J.L. Balcázar  Clinical Microbiology and Infection 
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
Localized Mycobacterium avium complex infection in a patient on HAART
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients  D. He, S. Guo, P. Zhu, S. Tao, M. Li,
Presentation transcript:

Long-term hepatitis E viral load kinetics in an immunocompromised patient treated with ribavirin  J. Ambrosioni, A. Mamin, A. Hadengue, M. Bernimoulin, K. Samii, C. Landelle, F. Negro, L. Kaiser  Clinical Microbiology and Infection  Volume 20, Issue 10, Pages O718-O720 (October 2014) DOI: 10.1111/1469-0691.12576 Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 HEV kinetics in an immunosuppressed, chronically infected patient receiving long-term rivabirin therapy and several months of alemtuzumab. HEV, hepatitis E virus; RBV, ribavirin; CT, threshold cycle; LOD, limit of detection. Clinical Microbiology and Infection 2014 20, O718-O720DOI: (10.1111/1469-0691.12576) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.